US Stock Market Move | Announces a full stock merger agreement with Quanterix (QTRX.US), Akoya Biosciences (AKYA.US) rises over 16%

On Friday, Akoya Biosciences (AKYA.US) saw its stock price rise, increasing by over 16% to $3.09 at the time of writing. The company announced a full stock merger agreement with Quanterix (QTRX.US). According to the agreement, the transaction is expected to be completed in the second quarter of 2025. The merged company will operate under the name Quanterix and will be led by the current CEO of Quanterix, Masoud Toloue. After the transaction is completed, Quanterix shareholders will own approximately 70% of the combined company. This merger will integrate the resources and technologies of both companies in the life sciences field, bringing greater value to shareholders and customers.